| 英文别名 |
(3,3-Difluoropyrrolidin-1-yl)[(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl]methanone;(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone;GOSOGLIPTIN;(3,3-Difluoro-1-pyrrolidinyl)[(2S,4S)-4-[4-(2-pyrimidinyl)-1-piperazinyl]-2-pyrrolidinyl]methanone (ACI);Pyrrolidine, 3,3-difluoro-1-[[(2S,4S)-4-[4-(2-pyrimidinyl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]- (9CI);PF 00734200;PF 734200;Q27077831;PF-00734200;CS-6619;GTPL7413;(3,3-Difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone;MS-25863;CHEBI:177858;Gosogliptin [USAN:INN];869490-23-3 (free base);(3,3-diluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone;PF-00734200;PF-734200;GOSOGLIPTIN [WHO-DD];BDBM50249479;GOSOGLIPTIN [INN];SCHEMBL197108;DPP-IV-Inhibitor;(3,3-difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone;GI718UO477;2-(4-{(3s,5s)-5-[(3,3-Difluoropyrrolidin-1-Yl)carbonyl]pyrrolidin-3-Yl}piperazin-1-Yl)pyrimidine;AKOS030531770;DB08382;Gosogliptin [USAN];869490-23-3;PF-734200;D09625;cis-(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone;CHEMBL515387;UNII-GI718UO477;DTXSID601007213;Gosogliptin Hydrochloride;DB-321982;NS00071677;QWEWGXUTRTXFRF-KBPBESRZSA-N;MFCD16038043;Gosogliptin (USAN/INN);G13868;Methanone, (3,3-difluoro-1-pyrrolidinyl)((2S,4S)-4-(4-(2-pyrimidinyl)-1-piperazinyl)-2-pyrrolidinyl)-;PF-734,200;HY-10287;869490-47-1 |